Search Results - "Couzens, Steve"

Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia by FREEMAN, Sylvie D, VIRGO, Paul, COUZENS, Steve, GRIMWADE, David, RUSSELL, Nigel, HILLS, Robert K, BURNETT, Alan K

“…Older patients with acute myeloid leukemia (AML) have a high relapse rate after standard chemotherapy. We investigated whether measuring chemotherapy…”
Get full text

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations by Freeman, Sylvie D, Hills, Robert K, Virgo, Paul, Khan, Naeem, Couzens, Steve, Dillon, Richard, Gilkes, Amanda, Upton, Laura, Nielsen, Ove Juul, Cavenagh, James D, Jones, Gail, Khwaja, Asim, Cahalin, Paul, Thomas, Ian, Grimwade, David, Burnett, Alan K, Russell, Nigel H

“…Purpose We investigated the effect on outcome of measurable or minimal residual disease (MRD) status after each induction course to evaluate the extent of its…”
Get full text

IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia by Hewamana, Saman, Pepper, Chris, Couzens, Steve, Thomas, Alun, Knapper, Steven

“…As IgM multiple myeloma is a rare poorly characterised disease entity; there is only limited published data on its clinical, microscopic and immunophenotypic…”
Get full text

An immunophenotypic pre‐treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38low blasts by Khan, Naeem, Freeman, Sylvie D., Virgo, Paul, Couzens, Steve, Richardson, Peter, Thomas, Ian, Grech, Angela, Vyas, Paresh, Grimwade, David, Russell, Nigel H., Burnett, Alan K., Hills, Robert K.

“…Summary Many older patients with acute myeloid leukaemia (AML) that receive standard intensive chemotherapy fail to achieve complete remission (CR). Upfront…”
Get full text

An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38 low blasts by Khan, Naeem, Freeman, Sylvie D, Virgo, Paul, Couzens, Steve, Richardson, Peter, Thomas, Ian, Grech, Angela, Vyas, Paresh, Grimwade, David, Russell, Nigel H, Burnett, Alan K, Hills, Robert K

“…Many older patients with acute myeloid leukaemia (AML) that receive standard intensive chemotherapy fail to achieve complete remission (CR). Upfront…”
Get full text

Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively by Freeman, Sylvie, Hills, Robert, Virgo, Paul, Couzens, Steve, Lowdell, Mark W, McNamara, Christopher J, White, Paul, Burnett, Alan

“…Abstract 2714 The majority of acute myeloid leukaemia (AML) patients are older than 60 years but little progress has been made in improving their poor outcome…”
Get full text

Molecular evidence for a common leukaemic progenitor in acute mixed lymphoid and myeloid leukaemia by Lim, S H, Culligan, D, Couzens, S, Fisher, J, John, S, Pollard, P, Burnett, A, Whittaker, J

“…De novo acute leukaemia presenting with a mixed lymphoid and myeloid leukaemic population has rarely been described. We have used the consensus Ig heavy chain…”
Get more information